Dermatitis and Eczema at the Military Board: Article 62 Explained

Reviewed by the LabReadAI medical team
Dermatitis and Eczema at the Military Board: Article 62 Explained

The short answer: atopic dermatitis and eczema are named explicitly in article 62 of the Schedule of Diseases, and with a confirmed relapsing course they yield category V in column I — "limited fitness". But the diagnosis alone is not enough: the regulation counts the percentage of affected skin, the number of flares over three years and requires inpatient confirmation. Seborrhoeic dermatitis, meanwhile, is not mentioned in the clauses at all — worth knowing in advance.

Which fitness category dermatitis and eczema yield

Article 62, "Diseases of the skin and subcutaneous tissue", distributes categories across three columns: I — registration and conscription, II — conscript service, III — contract and officers.

What the records show Clause Column I (conscription)
Treatment-resistant extensive forms with lichenification or exudation «a» D — unfit
Extensive and frequently relapsing forms; chronic urticaria and angioedema «b» V — limited fitness
Extensive rarely relapsing OR limited frequently relapsing «v» V — limited fitness
Limited and rarely relapsing forms «g» V — limited fitness
Forms in stable remission «d» B-3 — fit with restrictions

As with other dermatoses, three clauses converge on one category V in column I. The distinction matters for column III, where «b» gives "B (V - IND)", «v» gives B and «g» already gives A.

Who is named in article 62 and who is not

The clauses list the diseases by name:

v) extensive and rarely relapsing forms of psoriasis, atopic dermatitis, neurodermatitis, eczema and lichen planus, limited and frequently relapsing forms of psoriasis, atopic dermatitis, neurodermatitis, eczema and lichen planus…

Atopic dermatitis, neurodermatitis and eczema are here. Seborrhoeic dermatitis is not. The explanatory notes do use the phrase "or other chronic dermatoses", but that concerns counting relapse frequency and does not by itself add a disease to the clauses. What this means in a specific case is for the board to decide from your records, and automatic application of the article should not be assumed. If scaling on the scalp and face is the only complaint, it helps to understand how seborrhoea differs from other causes.

The extensive-form threshold in percent

The regulation sets the boundary as a number, not a judgement:

An extensive form of psoriasis, eczema, atopic dermatitis, neurodermatitis or lichen planus means skin involvement of more than 10 percent of the entire body surface, except for lesions of the face and neck, genitals, hands and feet, where more than 2 percent is sufficient.

For eczema this matters especially: hand eczema is a classic presentation, and there the threshold is five times lower. Two palms of affected skin on the hands already make an extensive form, while the same area on the trunk stays limited. So the dermatologist's conclusion must state both the percentage and the anatomical regions.

How flares are counted over three years

Frequently relapsing forms… are cases of exacerbation at least twice a year over the past three years.

Rarely relapsing forms… are cases of exacerbation at least once during the past three years.

Stable remission of a chronic dermatosis is diagnosed when there have been no exacerbations for more than 3 years.

The count runs on recorded visits. Atopic dermatitis that flares every winter but is treated at home with a cream formally never flares — the chart is empty. This is the most common and most painful loss.

Urticaria: separate conditions

Chronic urticaria and recurrent angioedema are named in clause «b», but with their own threshold:

Persons with chronic urticaria and (or) recurrent angioedema are assessed under clause «b» only where inpatient treatment over 4 weeks has failed, manifested by recurrence of lesions (at least twice a week) despite systemic therapy.

So what is required is not merely the diagnosis but documented failure of inpatient treatment: four weeks of therapy with lesions recurring at least twice a week despite it.

Why the article does not apply without inpatient care

Assessment of persons with chronic dermatoses is carried out only where the relapsing course is confirmed during an examination in inpatient conditions in medical organisations providing care in the field of "dermatovenereology".

Outpatient entries are not enough. For clause «a» the bar is higher still: inpatient treatment at least once every six months for no less than three consecutive years, plus failure of systemic immunosuppressive and biologic therapy.

What your records must contain

  • A discharge summary from a dermatovenereology inpatient unit confirming the relapsing course.
  • Percentage of involvement and location — noting hands, feet, face and neck separately.
  • A three-year history of flares with dates and treatments.
  • The regulation's own wording in the conclusion: "extensive", "frequently relapsing", "stable remission".
  • Where the cause is allergic — the work-up; what allergy testing and immunoglobulin E actually show is worth understanding beforehand.

The chart code is L20 for atopic dermatitis; it records the diagnosis but neither the extent nor the flare frequency.

What is usually missing

  • Flares were self-treated and never entered the chart.
  • The record says "dermatitis" without the form — atopic, seborrhoeic, contact are different lines of the regulation.
  • No percentages and no anatomical regions.
  • No dermatovenereology admission at all.
  • For urticaria, the failure of four weeks of therapy is not documented.

Questions for your doctor

  • Which form exactly is in my diagnosis, and does it match the wording of article 62?
  • What percentage of the surface is affected and which regions?
  • How many documented flares do I have over three years?
  • Was there an inpatient work-up, and is there a discharge summary?
  • If I have urticaria — is the failure of systemic therapy documented?

Skin conditions at departmental boards

The above concerns assessment under Government Decree No. 565. The Interior Ministry, National Guard, Federal Security Service and Emergencies Ministry use their own schedules of diseases with their own requirements for dermatoses. A review under article 62 shows the state of your records but is not their regulation.

The short version

Atopic dermatitis and eczema with a confirmed relapsing course yield category V in column I, whether the form is extensive or limited. Three things decide: the percentage of involvement adjusted for location, the number of documented flares over three years, and inpatient confirmation. Seborrhoeic dermatitis is not named in the clauses, which is worth knowing in advance. Only the military medical board determines the fitness category.

Frequently asked questions

  • With a confirmed relapsing course — yes: in column I that is category V. Atopic dermatitis is named explicitly in clauses «b», «v» and «g» of article 62, and all three give a conscript the same category. The exception is stable remission longer than three years, which brings clause «d» and category B-3. The code L20 in the chart decides nothing on its own: percentages, flare dates and inpatient confirmation are what count.

  • The hands are exactly where the extensive-form threshold drops from 10 % to 2 % of body surface. Hand eczema therefore reaches the extensive form far more often than the same area on the trunk. But in column I the category is the same either way — V, provided the relapsing course is confirmed.

  • It is not named in the clauses of article 62: the list is psoriasis, atopic dermatitis, neurodermatitis, eczema and lichen planus. The notes mention "other chronic dermatoses", but that phrase concerns counting relapse frequency rather than extending the list. Automatic application of the article should not be assumed — the board decides from the records as a whole.

  • For a frequently relapsing form — at least two a year over the past three years; for a rarely relapsing one — at least one in those three years. Only recorded visits count. Flares you got through at home do not exist for the board, however severe they were.

  • Yes. Article 62 applies only where the relapsing course is confirmed by an inpatient examination in dermatovenereology. That is a direct provision and outpatient entries cannot substitute for it. If there has been no admission, the board will order further examination.

  • It is named in clause «b», but with a separate condition: assessment under it happens only where four weeks of inpatient treatment fail and lesions recur at least twice a week despite systemic therapy. Documented treatment failure is required, not merely the diagnosis.

  • Article 62 sets no direct laboratory criteria — it rests on area, flare frequency and inpatient confirmation. But a work-up helps establish the nature of the disease and shape treatment, and therefore the history of visits: what immunoglobulin E shows and how allergy testing is done are covered separately.

  • Gather everything you have: discharge summaries, dermatologist conclusions, records of flares, test results. The wording is what matters — whether it contains percentages, locations, the phrases "frequently relapsing" or "remission", and whether there was an admission. To see what the board actually sees and what is missing, the records can be reviewed against the Schedule of Diseases.

For informational purposes only

This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Please consult a healthcare professional for medical guidance.

Have your records read against the Schedule of DiseasesUpload your discharge summaries, conclusions and scans — we show which articles relate to your picture, what the examinations confirm and what your records are missing. Review my records
Still have questions about your health?Ask the AI assistant in plain words — about symptoms, how you feel, sleep, or what a value means. No files needed, first question free. Ask AI about health